The 90-day mortality of patients with HBV-advanced fibrosis (AST/ALT ratio > 1.08) was significantly higher than that in patients with AST/ALT ratio ≤ 1.08 (χ2 = 20.65, p < 0.001; Figure 3A). This evidence concerns the gene GPT and fibrosis.